Pub Date : 2024-03-27DOI: 10.31053/1853.0605.v81.n1.44419
Hugo Ramos, Mario Altieri
El diagnóstico de Cardiomiopatía Cirrótica está basado en la presencia de cirrosis hepática avanzada con alteraciones de la función cardíaca sin cardiopatía pre-existente, pero en gran parte de su evolución natural ésta es subclínica. Por ello son imprescindibles los estudios complementarios no invasivos para confirmar el diagnóstico y su rol pronóstico en pacientes con o sin trasplante hepático. En esta segunda parte revisamos los métodos de diagnóstico desde el ECG hasta las imágenes de resonancia magnética cardíaca.
{"title":"Cardiomiopatía cirrótica – ¿Realidad clínica o simple curiosidad académica? Revisión.","authors":"Hugo Ramos, Mario Altieri","doi":"10.31053/1853.0605.v81.n1.44419","DOIUrl":"10.31053/1853.0605.v81.n1.44419","url":null,"abstract":"<p><p>El diagnóstico de Cardiomiopatía Cirrótica está basado en la presencia de cirrosis hepática avanzada con alteraciones de la función cardíaca sin cardiopatía pre-existente, pero en gran parte de su evolución natural ésta es subclínica. Por ello son imprescindibles los estudios complementarios no invasivos para confirmar el diagnóstico y su rol pronóstico en pacientes con o sin trasplante hepático. En esta segunda parte revisamos los métodos de diagnóstico desde el ECG hasta las imágenes de resonancia magnética cardíaca.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-27DOI: 10.31053/1853.0605.v81.n1.42231
María Virginia Boaglio, Gianmarco Llarena Billia, Ingrid Strusberg
Teleconsultation is one of the assets of telemedicine that allows medical professionals to provide diagnostic or therapeutic advice to patients through electronic means. The objective of this study was to estimate the frequency of teleconsultation implementation in hospitals in the city of Cordoba from 2020 to 2022. A descriptive, observational and cross-sectional study was carried out, providing an online survey (Google Forms) to hospital representatives in Córdoba. Descriptive statistics were used. The study was conducted in 30 out of the 50 hospitals in the city, including 17 private (57%) and 13 public institutions (43%). Teleconsultation was provided by a higher percentage of private healthcare facilities (82%) compared to public ones (77%). The results showed that the SARS-CoV-2 pandemic was the main driver behind the implementation of teleconsultation, with 92% of all hospitals having implemented it due to the pandemic while the remaining 8% had already offered this service prior to the pandemic. The most requested services were Internal Medicine and Infectology, and phone calls were the most commonly used tool. Among the hospitals that did not offer teleconsultation, 67% did not plan to do so in the future, while the remaining 33% were making arrangements for its implementation in 2023. Although the pandemic catalyzed the implementation of teleconsultations in most hospitals, there are still some institutions that do not plan to incorporate this modality. This study provides valuable data for improving future medical care strategies in the city of Cordoba.
{"title":"[Implementation of teleconsultation in hospitals in the city of Cordoba during the SARS-CoV-2 pandemic]","authors":"María Virginia Boaglio, Gianmarco Llarena Billia, Ingrid Strusberg","doi":"10.31053/1853.0605.v81.n1.42231","DOIUrl":"10.31053/1853.0605.v81.n1.42231","url":null,"abstract":"<p><p>Teleconsultation is one of the assets of telemedicine that allows medical professionals to provide diagnostic or therapeutic advice to patients through electronic means. The objective of this study was to estimate the frequency of teleconsultation implementation in hospitals in the city of Cordoba from 2020 to 2022. A descriptive, observational and cross-sectional study was carried out, providing an online survey (Google Forms) to hospital representatives in Córdoba. Descriptive statistics were used. The study was conducted in 30 out of the 50 hospitals in the city, including 17 private (57%) and 13 public institutions (43%). Teleconsultation was provided by a higher percentage of private healthcare facilities (82%) compared to public ones (77%). The results showed that the SARS-CoV-2 pandemic was the main driver behind the implementation of teleconsultation, with 92% of all hospitals having implemented it due to the pandemic while the remaining 8% had already offered this service prior to the pandemic. The most requested services were Internal Medicine and Infectology, and phone calls were the most commonly used tool. Among the hospitals that did not offer teleconsultation, 67% did not plan to do so in the future, while the remaining 33% were making arrangements for its implementation in 2023. Although the pandemic catalyzed the implementation of teleconsultations in most hospitals, there are still some institutions that do not plan to incorporate this modality. This study provides valuable data for improving future medical care strategies in the city of Cordoba.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 1","pages":"128-142"},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-27DOI: 10.31053/1853.0605.v81.n1.41876
Pablo Gulayin, Laura Gutierrez, Fernando Lanas, Nora Mores, Jacqueline Ponzo, Matías Calandrelli, Rosana Poggio, Vilma Irazola
Introduction: Current recommendations for cardiovascular disease (CVD) prevention are guided CVD risk classification. This study aims to analyze the level of compliance with pharmacological and non-pharmacological recommendations outlined in the World Health Organization (WHO) CVD prevention clinical practice guideline within the general population of two cities in Argentina.
Methods: We analyzed the compliance with preventive recommendations from the WHO 2007 Guidelines for Management of Cardiovascular Risk in two cities of Argentina participating in the CESCAS population-based study in the Southern Cone of Latin America.
Results: 3990 participants were included. Considering the WHO recommendations, the use of antiplatelet medication was 5.6% (95% CI 3.5, 8.9) in primary prevention and 20.5% (95%= CI 16.0, 25.9) in secondary prevention. Regarding lipid-lowering medication, it was 6.7% (CI 95%= 4.4, 10.1) and 15.4% (CI 95%= 11.6, 20.1), respectively. As per non-pharmacological recommendations in the general population: low intake of fruit and vegetables was 78.4% (CI 95%= 76.8, 79.9); low physical activity was 26.9% (CI 95%= 25.3, 28.5), current cigarette smoking was 28.3% (CI 95%= 26.6, 30.0), overweight/obesity was 73.9% (CI 95%= 72.3, 75.6), and excessive alcohol intake was 2.6% (CI 95%= 2.1, 3.4).
Conclusions: It was observed a significantly low compliance with pharmacological and non-pharmacological recommendations for CVD prevention in the general population of two cities in Argentina. Urgent efforts are needed to improve compliance to cardiovascular preventive recommendations promoted by CPG, especially in Low- and Middle- Income Countries.
{"title":"Compliance with a WHO guideline for cardiovascular disease prevention. A population based cross-sectional study in Argentina.","authors":"Pablo Gulayin, Laura Gutierrez, Fernando Lanas, Nora Mores, Jacqueline Ponzo, Matías Calandrelli, Rosana Poggio, Vilma Irazola","doi":"10.31053/1853.0605.v81.n1.41876","DOIUrl":"10.31053/1853.0605.v81.n1.41876","url":null,"abstract":"<p><strong>Introduction: </strong>Current recommendations for cardiovascular disease (CVD) prevention are guided CVD risk classification. This study aims to analyze the level of compliance with pharmacological and non-pharmacological recommendations outlined in the World Health Organization (WHO) CVD prevention clinical practice guideline within the general population of two cities in Argentina.</p><p><strong>Methods: </strong>We analyzed the compliance with preventive recommendations from the WHO 2007 Guidelines for Management of Cardiovascular Risk in two cities of Argentina participating in the CESCAS population-based study in the Southern Cone of Latin America.</p><p><strong>Results: </strong>3990 participants were included. Considering the WHO recommendations, the use of antiplatelet medication was 5.6% (95% CI 3.5, 8.9) in primary prevention and 20.5% (95%= CI 16.0, 25.9) in secondary prevention. Regarding lipid-lowering medication, it was 6.7% (CI 95%= 4.4, 10.1) and 15.4% (CI 95%= 11.6, 20.1), respectively. As per non-pharmacological recommendations in the general population: low intake of fruit and vegetables was 78.4% (CI 95%= 76.8, 79.9); low physical activity was 26.9% (CI 95%= 25.3, 28.5), current cigarette smoking was 28.3% (CI 95%= 26.6, 30.0), overweight/obesity was 73.9% (CI 95%= 72.3, 75.6), and excessive alcohol intake was 2.6% (CI 95%= 2.1, 3.4).</p><p><strong>Conclusions: </strong>It was observed a significantly low compliance with pharmacological and non-pharmacological recommendations for CVD prevention in the general population of two cities in Argentina. Urgent efforts are needed to improve compliance to cardiovascular preventive recommendations promoted by CPG, especially in Low- and Middle- Income Countries.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 1","pages":"96-114"},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.31053/1853.0605.v80.n4.42544
Eduardo Cuestas
.
.
{"title":"[Clinical reasoning and artificial intelligence.","authors":"Eduardo Cuestas","doi":"10.31053/1853.0605.v80.n4.42544","DOIUrl":"10.31053/1853.0605.v80.n4.42544","url":null,"abstract":"<p><p>.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"306-310"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.31053/1853.0605.v80.n4.42874
Paula Carolina Luna, María Eugenia Abad, Margarita Larralde, Paula Boggio, Bruno Ferrari, María Fernanda Maccario, Carla Castro, Silvia Moreno, Débora Kaplan, Cristina Echeverría
Introduction: in one third of patients with psoriasis, symptoms start during childhood and adolescence, with a strong emotional and psychosocial impact.
Objective: to develop a guideline for the systemic treatment of psoriasis in pediatric patients by means of recommendations based on the best available evidence.
Materials and methods: Sources: articles indexed in PubMed, Epistemonikos, Google Scholar, Cochrane Library and Scielo, published between January 2010 and May 2022, in English, Spanish and Portuguese. Study selection: evidence-based clinical practice guidelines, systematic reviews, meta-analyses, randomized controlled studies, observational studies (case-control, cohort studies, real-life registries) and evaluations of biosimilar drugs in patients up to and including 17 years of age were considered. The keywords "psoriasis" and "treatment" were used in all three languages. Data extraction: the literature was evaluated using Grading of Recommendations Assessment, Development and Evaluation (GRADE) recommendations. Data synthesis: evidence tables were developed and analyzed by the expert committee. The questions for the development of recommendations were based on the PICO system (population, intervention, comparison, outcome).
Results: A total of 8 recommendations and 7 points of good practice were developed. The direction and strength of the recommendations were expressed according to the GRADE system.
Conclusions: the final decision on a specific therapy should be based on the best opinion of the treating physician, the individual characteristics, and the values and preferences of the patients and their caregivers.
{"title":"[Recommendations for psoriasis treatment in Pediatrics].","authors":"Paula Carolina Luna, María Eugenia Abad, Margarita Larralde, Paula Boggio, Bruno Ferrari, María Fernanda Maccario, Carla Castro, Silvia Moreno, Débora Kaplan, Cristina Echeverría","doi":"10.31053/1853.0605.v80.n4.42874","DOIUrl":"10.31053/1853.0605.v80.n4.42874","url":null,"abstract":"<p><strong>Introduction: </strong>in one third of patients with psoriasis, symptoms start during childhood and adolescence, with a strong emotional and psychosocial impact.</p><p><strong>Objective: </strong>to develop a guideline for the systemic treatment of psoriasis in pediatric patients by means of recommendations based on the best available evidence.</p><p><strong>Materials and methods: </strong>Sources: articles indexed in PubMed, Epistemonikos, Google Scholar, Cochrane Library and Scielo, published between January 2010 and May 2022, in English, Spanish and Portuguese. Study selection: evidence-based clinical practice guidelines, systematic reviews, meta-analyses, randomized controlled studies, observational studies (case-control, cohort studies, real-life registries) and evaluations of biosimilar drugs in patients up to and including 17 years of age were considered. The keywords \"psoriasis\" and \"treatment\" were used in all three languages. Data extraction: the literature was evaluated using Grading of Recommendations Assessment, Development and Evaluation (GRADE) recommendations. Data synthesis: evidence tables were developed and analyzed by the expert committee. The questions for the development of recommendations were based on the PICO system (population, intervention, comparison, outcome).</p><p><strong>Results: </strong>A total of 8 recommendations and 7 points of good practice were developed. The direction and strength of the recommendations were expressed according to the GRADE system.</p><p><strong>Conclusions: </strong>the final decision on a specific therapy should be based on the best opinion of the treating physician, the individual characteristics, and the values and preferences of the patients and their caregivers.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"523-537"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.31053/1853.0605.v80.n4.42272
Carolina Pintos, Mariana Andrea Burgos, Natalia Inés Pasik, Sofía Piccioli, María Florencia Grande Ratti, María Paula Russo
Objective: To estimate the proportion of individuals with established Type 2 Diabetes Mellitus (T2DM) and Cardiovascular Disease (CVD) who are receiving pharmacological anti-diabetic treatment with evidence of cardiovascular benefit at a hospital in Argentina.
Materials and methods: Cross-sectional study conducted at the Italian Hospital of Buenos Aires. A consecutive sample of adult patients affiliated with the institutional prepaid health plan active in March 2020, diagnosed with T2DM and established CVD, was included. Data were collected from the Electronic Health Record. The proportion of pharmacological adequacy (combined use of metformin plus sodium-glucose co-transporter 2 inhibitors and/or glucagon-like peptide 1 receptor agonists) was reported along with its respective 95% confidence interval (CI).
Results: A total of 1539 patients were included, with a mean age of 76.2 years; 65.3% were male, and 81.6% were overweight or obese. Hemoglobin A1c levels were recorded in the past year for 74.9% of patients, with an average value of 6.9% (SD 1.2). The most prescribed drugs were metformin (61.3%), insulin (26.7%), and gliptins (11%). Out of the total included patients, 82 exhibited pharmacotherapeutic adequacy for diabetes treatment, with a prevalence of 5.3% (95% CI 4.2-6.5).
Conclusions: The prevalence of prescribing anti-diabetic drugs with evidence of cardiovascular benefit was 5.3% (95% CI 4.2-6.5). This real-world evidence highlights the low frequency of prescribing this type of medication at the time of the study in a high cardiovascular risk population.
{"title":"[Real-world evidence on pharmacological appropriateness in type 2 diabetes mellitus and cardiovascular disease].","authors":"Carolina Pintos, Mariana Andrea Burgos, Natalia Inés Pasik, Sofía Piccioli, María Florencia Grande Ratti, María Paula Russo","doi":"10.31053/1853.0605.v80.n4.42272","DOIUrl":"10.31053/1853.0605.v80.n4.42272","url":null,"abstract":"<p><strong>Objective: </strong>To estimate the proportion of individuals with established Type 2 Diabetes Mellitus (T2DM) and Cardiovascular Disease (CVD) who are receiving pharmacological anti-diabetic treatment with evidence of cardiovascular benefit at a hospital in Argentina.</p><p><strong>Materials and methods: </strong>Cross-sectional study conducted at the Italian Hospital of Buenos Aires. A consecutive sample of adult patients affiliated with the institutional prepaid health plan active in March 2020, diagnosed with T2DM and established CVD, was included. Data were collected from the Electronic Health Record. The proportion of pharmacological adequacy (combined use of metformin plus sodium-glucose co-transporter 2 inhibitors and/or glucagon-like peptide 1 receptor agonists) was reported along with its respective 95% confidence interval (CI).</p><p><strong>Results: </strong>A total of 1539 patients were included, with a mean age of 76.2 years; 65.3% were male, and 81.6% were overweight or obese. Hemoglobin A1c levels were recorded in the past year for 74.9% of patients, with an average value of 6.9% (SD 1.2). The most prescribed drugs were metformin (61.3%), insulin (26.7%), and gliptins (11%). Out of the total included patients, 82 exhibited pharmacotherapeutic adequacy for diabetes treatment, with a prevalence of 5.3% (95% CI 4.2-6.5).</p><p><strong>Conclusions: </strong>The prevalence of prescribing anti-diabetic drugs with evidence of cardiovascular benefit was 5.3% (95% CI 4.2-6.5). This real-world evidence highlights the low frequency of prescribing this type of medication at the time of the study in a high cardiovascular risk population.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"335-351"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.31053/1853.0605.v80.n4.42580
Brian Johan Bustos-Viviescas, Rafael Enrique Lozano Zapata, Carlos Enrique García Yerena
Long COVID is a multi-organ pathology with important sequelae that affect the health and welfare of survivors from the cellular bioenergetics, in this case, the importance of considering the acid-base balance within the processes of evaluation and treatment of long COVID by health and sports professionals was addressed, given that different investigations have found important modifications in mitochondrial function that result in ventilation failures, causing alterations in the compensation-decompensation of respiratory and renal pH control (metabolic-respiratory acidosis and alkalosis).
{"title":"[Acid-base balance and long COVID: comments on metabolic-respiratory alterations].","authors":"Brian Johan Bustos-Viviescas, Rafael Enrique Lozano Zapata, Carlos Enrique García Yerena","doi":"10.31053/1853.0605.v80.n4.42580","DOIUrl":"10.31053/1853.0605.v80.n4.42580","url":null,"abstract":"<p><p>Long COVID is a multi-organ pathology with important sequelae that affect the health and welfare of survivors from the cellular bioenergetics, in this case, the importance of considering the acid-base balance within the processes of evaluation and treatment of long COVID by health and sports professionals was addressed, given that different investigations have found important modifications in mitochondrial function that result in ventilation failures, causing alterations in the compensation-decompensation of respiratory and renal pH control (metabolic-respiratory acidosis and alkalosis).</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"568-573"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.31053/1853.0605.v80.n4.43234
Norma Acerbi Cremades
{"title":"[Historic evocation]","authors":"Norma Acerbi Cremades","doi":"10.31053/1853.0605.v80.n4.43234","DOIUrl":"10.31053/1853.0605.v80.n4.43234","url":null,"abstract":"","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"311-313"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.31053/1853.0605.v80.n4.40922
Juan Bautista Del Valle, Marina Alonso Serena, Gabriel Ducrey, Jésica Lorena Savluk, Matías Adrián Borensztein
Introduction: The diagnosis of lung cancer, as well as that of lung nodules, is increasing. Percutaneous biopsy has become a transcendental tool for its diagnosis. Traditionally, computed tomography is used for these procedures because of its ability to clearly demonstrate bone and aerated lung. However, in selected cases it can be performed with ultrasound.
Methods: Retrospective study conducted between January 2020 and December 2021, during the SARS-CoV-2 pandemic. All patients had pleural-based lung lesions or pleural lesions, some with a known history of cancer.
Results: Thirty-six procedures were performed, in 32 (88.9%) the sample obtained presented diagnostic yield and the most used additional test was Immunohistochemistry in 23 (63.9%). Complications were reported in 5 patients (13.9%): 2 with mild pneumothorax, 2 with hemothorax (1 mild and 1 moderate) and 1 patient reported pain.
Conclusion: Ultrasound is a valid method to be used as a guide for biopsies of pleural and peripheral pulmonary lesions. The complications and diagnostic rate has been shown to be in line with the experience of other authors and international guidelines.
{"title":"[Ultrasound guided biopsy of lung tumors: evaluation of efficacy and complications].","authors":"Juan Bautista Del Valle, Marina Alonso Serena, Gabriel Ducrey, Jésica Lorena Savluk, Matías Adrián Borensztein","doi":"10.31053/1853.0605.v80.n4.40922","DOIUrl":"10.31053/1853.0605.v80.n4.40922","url":null,"abstract":"<p><strong>Introduction: </strong>The diagnosis of lung cancer, as well as that of lung nodules, is increasing. Percutaneous biopsy has become a transcendental tool for its diagnosis. Traditionally, computed tomography is used for these procedures because of its ability to clearly demonstrate bone and aerated lung. However, in selected cases it can be performed with ultrasound.</p><p><strong>Methods: </strong>Retrospective study conducted between January 2020 and December 2021, during the SARS-CoV-2 pandemic. All patients had pleural-based lung lesions or pleural lesions, some with a known history of cancer.</p><p><strong>Results: </strong>Thirty-six procedures were performed, in 32 (88.9%) the sample obtained presented diagnostic yield and the most used additional test was Immunohistochemistry in 23 (63.9%). Complications were reported in 5 patients (13.9%): 2 with mild pneumothorax, 2 with hemothorax (1 mild and 1 moderate) and 1 patient reported pain.</p><p><strong>Conclusion: </strong>Ultrasound is a valid method to be used as a guide for biopsies of pleural and peripheral pulmonary lesions. The complications and diagnostic rate has been shown to be in line with the experience of other authors and international guidelines.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"439-455"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.31053/1853.0605.v80.n4.40821
Diego Odetto, Maria Celeste Puga, Guido Martin Rey Valzacchi, Jose Martin Saadi, Liliana Beatriz Zamora, Maria Cecilia Riggi, Myriam Beatriz Perrotta
Introduction: Endometrial cancer is the second most frequent gynecological tumor in Argentina, representing 6% of all cancers in women. The objective of this study is to evaluate the oncological and perioperative results in patients with high-risk endometrial cancer (HREC) limited to the uterus, treated at the Hospital Italiano de Buenos Aires, between January 2010-2018.
Methods: Retrospective cohort study that evaluated perioperative results, disease-free survival at 2, 4 years in patients with HREC.
Results: Of a total of 123 patients, 74 met the inclusion criteria. Serous tumors were the most frequent histological type, n=38 (51%), while dedifferentiated tumors were the least frequent, n=2 (3%). Of all the patients included, 56 (76%) received at least one adjuvant treatment. Taxol platinum-based chemotherapy was implemented in 28 patients (38%), while 24 (33%) received a combination of chemotherapy and radiotherapy. The median follow-up time was 2.9 years. Disease-free survival in patients with stage IA at 2 and 4 years was 71% (95% CI 55-82) and 63% (CI 46-76), respectively, while those with stage IB were 53 (95% CI 33-70) and 38 (95% CI 19-58). Regarding the surgical approach, no significant differences were found in disease-free or overall survival when comparing the laparoscopic with the laparotomy approach (p=0.06).
Conclusion: Only the FIGO stage showed an increased probability of death or relapse regardless of the type of adjuvant treatment and the type of surgery approach. Perioperative complications were similar in both approaches.
简介在阿根廷,子宫内膜癌是第二大妇科肿瘤,占妇女癌症总数的 6%。本研究旨在评估2010年1月至2018年1月期间在布宜诺斯艾利斯意大利医院接受治疗的局限于子宫的高危子宫内膜癌(HREC)患者的肿瘤学和围手术期疗效。方法:回顾性队列研究,评估HUSC患者的围手术期疗效、2年和4年的无病生存率。 结果:74 名患者符合纳入标准。浆液性肿瘤发病率最高,为38例(51%),未分化肿瘤发病率最低,为2例(3%)。56名(76%)患者接受了至少一种辅助治疗。28名患者(38%)接受了全身治疗,24名患者(33%)接受了化疗和放疗联合治疗。 中位随访时间为 2.9 年。IA期患者2年和4年的无病生存率分别为71%(95% CI 55-82)和63%(CI 46-76),而IB期患者的无病生存率分别为53%(95% CI 33-70)和38%(95% CI 19-58)。在手术方式方面,无病生存率和围手术期并发症无明显差异。结论:无论采用哪种辅助治疗方法,只有FIGO分期显示死亡或复发的可能性增加。
{"title":"[High-risk endometrial carcinoma in early stages: Hospital Italiano de Buenos Aires, oncological results].","authors":"Diego Odetto, Maria Celeste Puga, Guido Martin Rey Valzacchi, Jose Martin Saadi, Liliana Beatriz Zamora, Maria Cecilia Riggi, Myriam Beatriz Perrotta","doi":"10.31053/1853.0605.v80.n4.40821","DOIUrl":"10.31053/1853.0605.v80.n4.40821","url":null,"abstract":"<p><strong>Introduction: </strong>Endometrial cancer is the second most frequent gynecological tumor in Argentina, representing 6% of all cancers in women. The objective of this study is to evaluate the oncological and perioperative results in patients with high-risk endometrial cancer (HREC) limited to the uterus, treated at the Hospital Italiano de Buenos Aires, between January 2010-2018.</p><p><strong>Methods: </strong>Retrospective cohort study that evaluated perioperative results, disease-free survival at 2, 4 years in patients with HREC.</p><p><strong>Results: </strong>Of a total of 123 patients, 74 met the inclusion criteria. Serous tumors were the most frequent histological type, n=38 (51%), while dedifferentiated tumors were the least frequent, n=2 (3%). Of all the patients included, 56 (76%) received at least one adjuvant treatment. Taxol platinum-based chemotherapy was implemented in 28 patients (38%), while 24 (33%) received a combination of chemotherapy and radiotherapy. The median follow-up time was 2.9 years. Disease-free survival in patients with stage IA at 2 and 4 years was 71% (95% CI 55-82) and 63% (CI 46-76), respectively, while those with stage IB were 53 (95% CI 33-70) and 38 (95% CI 19-58). Regarding the surgical approach, no significant differences were found in disease-free or overall survival when comparing the laparoscopic with the laparotomy approach (p=0.06).</p><p><strong>Conclusion: </strong>Only the FIGO stage showed an increased probability of death or relapse regardless of the type of adjuvant treatment and the type of surgery approach. Perioperative complications were similar in both approaches.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"80 4","pages":"352-366"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}